Patient safety is of utmost importance to ALRAI, we encourage you providing us with any complain and side effect   related to ALRAI product even in cases where a relationship between the product and the effect is not established.         

By reporting the adverse drug reactions, you contribute in the collection of safety information process for each drug.     

Our pharmacovigilance department is solely dedicated to detecting and evaluating risk. In addition, they are responsible for proposing and developing measures to reduce such risks. Side effects are not always detectable in clinical trials, which are carried out on a relatively small sample of patients.  

However, once the product is placed on the market and administered to a greater number of patients, certain side effects and adverse events may emerge.     

The information you provide will help us meet our responsibility for reporting Advance Drug Reactions to regulatory authorities, we operate in total transparency with the Health Authorities of the countries where our medicinal products are available.

We stay in close communication and keep each other apprised of any adverse events or issue that may arise after taking one of our treatments.

In this way we work together to continuously improve patient safety.